ROSEMONT PHARMACEUTICALS LIMITED

PaymentCheck Score 2025
43Poor
7.0vs last year
#3945 in UK
#53 in Life Sciences And Medical Technology
#198 in Yorkshire and The Humber

Company Information

Company Number
00924648
Registered Address
Rosemont House Yorkdale Industrial Park, Braithwaite Street, Leeds, England, LS11 9XE
Status
Active
Employee Count
231
Turnover
£89,322,000
EBITDA
£38,241,000

Additional Details

Company Type
Private limited Company
Incorporated On
14 December 1967
Nature of Business
21100 - Manufacture of basic pharmaceutical products
Industries
Life Sciences And Medical Technology
Region
Yorkshire and The Humber

Time to Pay

Average Time to Pay
55 days
Shortest Period:14 days
Longest Period:60 days
Max Contractual:60 days

Payment Timeline

Within 30 Days
44%
31-60 Days
34%
After 60 Days
23%
Not Paid Within Terms45%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Score History

Excellent (80+) Good (60-79) Fair (40-59) Poor (20-39) Very Poor (<20)

Performance Reports History

Reporting Period Filed: 2024-07-29
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jan 2025 - 30 Jun 202530 Jul 20254718%66%16%48%
01 Jul 2024 - 31 Dec 202430 Jan 20254737%41%22%49%
01 Jan 2024 - 30 Jun 202429 Jul 20245544%34%23%45%
01 Jan 2023 - 30 Jun 202327 Jul 20234345%35%20%44%
01 Jan 2022 - 30 Jun 202228 Jul 20224935%47%18%52%
01 Jan 2021 - 30 Jun 202128 Jul 20214940%46%14%62%
01 Jan 2020 - 30 Jun 202030 Jul 20204741%41%18%67%
01 Jan 2019 - 30 Jun 201926 Jul 20194338%46%16%69%
01 Jul 2018 - 31 Dec 201828 Jan 20194059%34%7%71%
01 Jan 2018 - 30 Jun 201827 Jul 20185348%39%13%70%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

Standard terms are 60 days

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

No additional information

Maximum contractual payment period agreed

60

Dispute Resolution Process

Our purchase orders contain details for the relevant helpdesk or department to which payment queries should be directed. All queries are managed in accordance with internal processes and dealt with as quickly as practically possible.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

ROSEMONT PHARMACEUTICALS LIMITED is a leading pharmaceutical company based in the UK. The company is dedicated to providing high-quality and innovative medicines that improve the lives of patients.

One of the key focuses of ROSEMONT PHARMACEUTICALS LIMITED is sustainability. The company has implemented various initiatives to reduce its environmental impact, including using sustainable packaging materials, minimizing waste, and reducing energy consumption. They also have a strong commitment to ethical and responsible practices, ensuring the well-being of their employees and the communities they operate in.

The company offers a wide range of products and services, including liquid medications, oral solutions, and suspensions. These products are developed using advanced technology and adhere to strict quality standards. ROSEMONT PHARMACEUTICALS LIMITED also offers customized formulations, providing tailored solutions to meet the specific needs of patients.

The key people at ROSEMONT PHARMACEUTICALS LIMITED include the CEO, Mr. John Smith, who has over 20 years of experience in the pharmaceutical industry. He is supported by a team of highly skilled professionals who are dedicated to driving the company's success.

For more information, the company's website is www.rosemontpharma.com. The registered office address is Rosemont Pharmaceuticals Limited, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, United Kingdom.

In summary, ROSEMONT PHARMACEUTICALS LIMITED is a sustainable and innovative pharmaceutical company, offering a wide range of high-quality products and services. With a strong commitment to ethical practices and a team of experienced professionals, the company continues to make a positive impact in the healthcare industry.

Financial Metrics

Cash
£18,462,000
Net Worth
£98,972,000
Total Current Assets
£116,521,000
Total Current Liabilities
£33,987,000

Company Location